When was EXIT071 founded?

EXIT071 was founded in 2021 and raised its 1st funding round 1 year after it was founded.

Where is EXIT071 located?

EXIT071 is headquartered in Leiden, Netherlands.

How many employees does EXIT071 have?

As of May 31, 2026, the latest employee count at EXIT071 is 7.

Is EXIT071 a funded company?

EXIT071 is a funded company, having raised a total of $396K across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Feb 15, 2022.

When was the latest funding round of EXIT071?

EXIT071's latest funding was a $***** Grant (prize money) round on Apr 01, 2023, with participation from 1 investor.

Where does EXIT071 rank among its competitors?

EXIT071 ranks 32nd amongst 187 active competitors, of which 19 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was RevolKa, which secured $1.4M in May, 2025.

Who are the top competitors of EXIT071?

EXIT071's top competitors include Zephyr AI, Cosylab and Transaction Data Systems. Among them, RevolKa secured the most recent funding round in May, 2025.

EXIT071 - 2026 Company Profile, Team, Funding & Competitors

Most viewed in 2019

EXIT071 is a seed company based in Leiden (Netherlands), founded in 2021 by Thomas Hankemeier. It operates as a Provider of microfluidic technology development services. EXIT071 has raised $396K in funding. The company has 187 active competitors, including 19 funded and 19 that have exited. Its top competitors include companies like Zephyr AI, Cosylab and Transaction Data Systems.

Key Metrics

Founded Year

2021

Location

Leiden, Netherlands

Stage

Seed

Total Funding

$396K in 3 rounds

Latest Funding Round

Grant (prize money), Apr 01, 2023, $*****

Investors

InnovationQuarter & 3 more

Ranked

32^nd among 187 active competitors

Employee Count

7 as on May 31, 2026

Similar Companies

Zephyr AI & 214 more

View EXIT071's full profile

EXIT071 has raised a total funding of $396K over 3 rounds. Its first funding round was on Feb 15, 2022. Its latest funding round was a Grant (prize money) round on Apr 01, 2023 for $*****. 1 investor participated in its latest round. EXIT071 has 4 institutional investors.

Here is the list of recent funding rounds of EXIT071:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 01, 2023	1562301	Grant (prize money)	8446737	7231869	9466279	9316697
Jun 01, 2022	4937757	Grant (prize money)	7877222	2560127	6310428	Europa
Feb 15, 2022	9179688	Seed	5565211	1547094	1011736	UNIIQ & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of EXIT071's funding rounds and investors

The founders of EXIT071 is Thomas Hankemeier.

Here are the details of EXIT071's key team members:

Thomas Hankemeier: Co-Founder & Scientific Advisor of EXIT071.

View details of EXIT071's Founder profiles and Board Members

EXIT071's employee count trend

EXIT071 has 7 employees as of May 26. Here is EXIT071's employee count trend over the years:

Uncover EXIT071's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of EXIT071 include Zephyr AI, Cosylab and Transaction Data Systems. Here is the list of Top 10 competitors of EXIT071, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Zephyr AI 2020, United States, Series A	Provider of AI development services for biopharma sector	$130M	Lilly, Revolution & 13 others	56/100
2nd	Cosylab 2001, Ljubljana (Slovenia), Funding Raised	Provider of software solutions for biopharma and medical device industries	-	EIC Fund, Europa & 1 others	47/100
3rd	Transaction Data Systems 1977, Earth City (United States), Acquired	Provider of software development services to biopharma sector	-	-	46/100
4th	RevolKa 2021, Chuo City (Japan), Series A	Provider of AI development services for biopharma sector	$3.1M	D3, DEEPCORE & 3 others	45/100
5th	EDETEK 2009, Princeton (United States), Funding Raised	Provider of digital clinical trial solutions	-	LDV Partners	42/100
6th	Axle Informatics 2002, Bethesda (United States), Unfunded	Provider of software collaboration and laboratory informatics tools for biopharma sector	-	-	39/100
7th	Biogaran 1996, Colombes (France), Unfunded	Provider of software development services for biopharma sector	-	-	38/100
8th	Telescope Innovations 2019, Vancouver (Canada), Public	Develops software platforms for biopharma sector	-	New Age Ventures	38/100
9th	Dash Technologies 2010, Columbus (United States), Unfunded	Developer of software engineering and data analytics for healthcare organizations	-	-	37/100
10th	Xavo 2000, Bayreuth (Germany), Unfunded	Provider of software services for biopharma sector	-	-	37/100
32nd	EXIT071 2021, Leiden (Netherlands), Seed	Provider of microfluidic technology development services	$396K	InnovationQuarter, Europa & 2 others	26/100